Advancing the Future of Non‑Invasive Optical Diagnostics
CoraLuma is developing a reagent‑less, multi‑modal optical platform intended to explore new possibilities in continuous in‑vivo monitoring and point‑of‑care diagnostics. For decades, non‑invasive optical sensing has largely remained within academic research environments. CoraLuma aims to translate these scientific principles into investigational hardware that may one day support clinical workflows.
Our development efforts focus on engineering an integrated optoelectronic system designed to study vital‑sign dynamics, blood‑related spectral features, and structural tissue characteristics — without needles, enzymatic strips, or adhesive‑based sensors. These capabilities represent ongoing research and development, not validated clinical performance.
Our Mission
CoraLuma’s mission is to reduce discomfort and complexity in chronic‑care management and acute triage by advancing research into optical diagnostic systems designed to measure physiological signals directly from arterial blood volume.
Why CoraLuma?
- Completely Non‑Invasive — Investigational optical interrogation concepts designed to eliminate needles, skin‑puncturing probes, and chemical consumables.
- Multi‑Modal Spectral Engine — A Vis‑SWIR platform under development to explore a broad range of biochemical and physiological signatures.
- Direct Arterial Signal Access — Engineering approaches intended to isolate pulsatile arterial blood volume and reduce reliance on delayed interstitial‑fluid measurements.
- Advanced Calibration Research — Covariance‑based algorithms designed to model individual skin differences and reduce calibration burden.
These represent forward‑looking development goals, not FDA‑cleared diagnostic claims.